GlassScriptPhysician profile
Julie Lacombe
NPI 1225086424
$6,405.12
in general payments reported to CMS, 2019-2025
14 companies · $1,981 in 2025
The $1,981 reported for 2025 was more than what 83% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.63 · 2020: $160 · 2021: $186 · 2022: $2,338 · 2023: $255 · 2024: $1,405 · 2025: $1,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,602 · Food and Beverage: $811 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,601.95 |
| Food and Beverage | $810.92 |
| Education | $228.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,264.51 | 2022-2025 | |
| Medtronic, INC. | $1,748.49 | 2021-2025 | |
| Bluewind Medical | $1,141.29 | 2024 | Revi |
| Coloplast Corp | $417.87 | 2025 | |
| Sumitomo Pharma America, INC. | $266.57 | 2023-2025 | Gemtesa |
| Medtronic USA, INC. | $181.17 | 2019-2020 | |
| Boston Scientific Corporation | $161.37 | 2022-2025 | Axonics, Polyform |
| Urovant Sciences INC | $80.37 | 2022 | |
| Astellas Pharma US INC | $51.99 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $37.89 | 2025 | Bard Urinary Drainage Bag |
| Abc Home Medical Supply, INC. | $25.09 | 2024 | |
| Axonics, INC. | $21.60 | 2024 | Axonics |
| Caldera Medical, INC | $6.91 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Lacombe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.